SCHEMBL9056089

SCHEMBL9056089

CCn1cnc2c1c(=O)n(CCCCC(C)(C)O)c(=O)n2CC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 10/20 0.54
PDE4B Q07343 9/20 0.54
PDE4C Q08493 9/20 0.54
PDE4D Q08499 9/20 0.54
ADORA2A P29274 7/20 0.54
ADORA2B P29275 4/20 0.54
CYP1A2 P05177 2/20 0.47
BLM P54132 2/20 0.47
PMP22 Q01453 2/20 0.47
LMNA P02545 1/20 0.47
ESR1 P03372 1/20 0.47
MAPT P10636 1/20 0.47
NFKB1 P19838 1/20 0.47
ACHE P22303 1/20 0.47
CNOT7 Q9UIV1 3/20 0.45
CYP3A4 P08684 1/20 0.45
HSD17B10 Q99714 1/20 0.45
BRD4 O60885 1/20 0.44
BRD2 P25440 1/20 0.44
BRD3 Q15059 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9055007 0.99 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7360054 0.93 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL9057453 0.92 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL3847240 0.92 PDE4A (0.55) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7033527 0.91 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL19601304 0.91 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL9056614 0.89 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL14541204 0.89 ADORA2A (0.48) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL10346585 0.88 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7561563 0.87 POLB (0.55) PDE4APDE4BPDE4CPDE4DADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0413278-B1 Use of xanthine derivatives against peptic ulcers HOECHST JAPAN (JP) 1996-11-06 EP disclosed
US-5109003-A METHOD FOR THE TREATMENT OF PEPTIC ULCER DISEASE HOECHST JAPAN LIMITED (JP) 1992-04-28 US disclosed
EP-0413278-A2 Use of xanthine derivatives against peptic ulcers HOECHST JAPAN LIMITED (JP) 1991-02-20 EP disclosed